Biomet Knee Sales Aid 9% Growth In Reconstructive Implant Revenues
This article was originally published in The Gray Sheet
Executive Summary
Biomet knee sales growth of 15% helped drive a 9% advance in reconstructive implant revenue to $528.4 million for the firm's fiscal second quarter (ended Nov. 30), the company reported Jan. 6